Phathom Pharmaceuticals (PHAT) Asset Utilization Ratio (2023 - 2026)

Phathom Pharmaceuticals (PHAT) has 4 years of Asset Utilization Ratio data on file, last reported at 0.73 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.73, up 198.32% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.73 (up 198.32% YoY), and the FY2025 annual result was 0.55, up 293.84% from the prior year.
• Asset Utilization Ratio grew to 0.73 in Q1 2026 per PHAT's latest filing, from 0.7 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.73 in Q1 2026 and troughed at 0.0 in Q4 2023.
• A 4-year average of 0.29 and a median of 0.19 in 2024 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2024 and 2026: Asset Utilization Ratio soared 6789.17% in 2024, then surged 198.32% in 2026.
• A 4-year view of Asset Utilization Ratio shows it stood at 0.0 in 2023, then soared by 6789.17% to 0.14 in 2024, then jumped by 385.68% to 0.7 in 2025, then climbed by 3.56% to 0.73 in 2026.
• Business Quant data shows PHAT's Asset Utilization Ratio at 0.73 in Q1 2026, 0.7 in Q4 2025, and 0.6 in Q3 2025.